Skip to main content
Fig. 3 | BMC Infectious Diseases

Fig. 3

From: Could widespread use of antiviral treatment curb the COVID-19 pandemic? A modeling study

Fig. 3

Percentage of infections averted for A Kenya, B Mexico, C United States and D Belgium. Percentage of infections averted (compared to a baseline of no antiviral treatment) assuming an epidemic wave with parameters similar to those of the Omicron epidemic wave (transmissibility, vaccine effectiveness, and vaccination coverage). For each country, the colors represent four possible values of AVT (25, 50, 75 or 100% reduction in viral transmission in treated symptomatic individuals) and a daily treatment initiation rate (DTIR) of 2–100% of adult symptomatic individuals within the first 5 days of symptoms

Back to article page